15 results on '"Waldstreicher, Joanne"'
Search Results
2. The Long-Term Effect Of Specific Type II 5α-Reductase Inhibition With Finasteride on Bone Mineral Density in Men: Results of a 4-Year Placebo Controlled Trial
3. Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia
4. Androgen antagonists: Potential role in prostate cancer prevention
5. Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride
6. SERUM PROSTATE SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF FUTURE PROSTATE GROWTH IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
7. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo
8. Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia
9. Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy?
10. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia
11. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia
12. A systemic type i 5 α-reductase inhibitor is ineffective in the treatment of acne vulgaris
13. Lowering LDL cholesterol with simvastatin, an HMG-CoA reductase inhibitor, does not affect luteal function in women
14. Biologic Variability of Prostate-Specific Antigen and its Usefulness as a Marker for Prostate Cancer: Effects of Finasteride
15. Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: Effects of finasteride
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.